Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Cervical Cancer, November 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 255 articles:
HTML format


 

Single Articles

  1. KIM JY, Hong J, Yoon J, Park J, et al
    Regularity of cervical cancer screening in Korea: analysis using national public data for 12 years.
    J Gynecol Oncol. 2023 Oct 16. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  2. MONTHATIP K, Boonnag C, Muangmool T, Charoenkwan K, et al
    A machine learning-based prediction model of pelvic lymph node metastasis in women with early-stage cervical cancer.
    J Gynecol Oncol. 2023 Oct 18. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  3. LIANG T, Lu T, Jia W, Li R, et al
    Knockdown of lncRNA MALAT1 induces pyroptosis by regulating the miR?124/SIRT1 axis in cervical cancer cells.
    Int J Oncol. 2023;63:138.
    PubMed    
    Abstract available

  4. AHMED F, Yang YJ, Samantasinghar A, Kim YW, et al
    Network-based drug repurposing for HPV-associated cervical cancer.
    Comput Struct Biotechnol J. 2023;21:5186-5200.
    PubMed    
    Abstract available

  5. MING C, Bai X, Zhao L, Yu D, et al
    RPL24 as a potential prognostic biomarker for cervical cancer treated by Cisplatin and concurrent chemoradiotherapy.
    Front Oncol. 2023;13:1131803.
    PubMed    
    Abstract available

  6. ZENG M, Zhang X, He L, Liu X, et al
    Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022.
    Virol J. 2023;20:254.
    PubMed    
    Abstract available

  7. WOLF B, Weydandt L, Dornhofer N, Hiller GGR, et al
    Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype.
    Sci Rep. 2023;13:18946.
    PubMed    
    Abstract available

  8. WEN F, Li C, Liang B, You J, et al
    Efficacy of high-dose-rate brachytherapy with different radiation source activities among cervical cancer patients and risk factors for long-term outcomes: A 6-year retrospective study.
    Brachytherapy. 2023 Oct 31:S1538-4721(23)01650.
    PubMed    
    Abstract available

  9. KOMBE AJK, Zoa-Assoumou S, Bounda GA, Nsole-Biteghe FA, et al
    Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis.
    Front Biosci (Landmark Ed). 2023;28:245.
    PubMed    
    Abstract available

  10. ELZEINY N, Sayed Shafei AE, Wagih S, Saad M, et al
    Phytochemicals in cervical cancer: an epigenetic overview.
    Epigenomics. 2023 Nov 2. doi: 10.2217/epi-2023-0181.
    PubMed    
    Abstract available

  11. MIAN DB, Koffi SV, Nsahlai CJ, Adjoby R, et al
    Knowledge, Attitudes and Behaviors of Clients Regarding Cervical Cancer Screening at Gynecology Consultations of the University Hospital of Cocody.
    J Obstet Gynaecol India. 2023;73.
    PubMed    
    Abstract available

  12. LE CT, Nguyen AQ, Thi Pham HD, Tran LT, et al
    Recurrent early-stage squamous cell carcinoma cervical cancer presenting with isolated ovary metastasis: a rare case report.
    Ann Med Surg (Lond). 2023;85:5662-5665.
    PubMed    
    Abstract available

  13. KUMARI S
    Screening for Cervical Cancer in Pregnancy.
    Oncol Rev. 2023;17:11429.
    PubMed    
    Abstract available

  14. ATENCHONG N, Olayinka O, Sesan OT, Akinyinka O, et al
    Reproductive health challenges among women in internally displaced camps in Benue State: A protocol for a community-based health education interventional study.
    Afr J Reprod Health. 2023;27:133-144.
    PubMed    
    Abstract available

  15. MUSA J, Kocherginsky M, Magaji FA, Maryam AJ, et al
    Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.
    Infect Agent Cancer. 2023;18:68.
    PubMed    
    Abstract available

  16. ISAJI Y, Tsuyoshi H, Tsujikawa T, Orisaka M, et al
    Prognostic value of (18)F-FDG PET in uterine cervical cancer patients with stage IIICr allocated by imaging.
    Sci Rep. 2023;13:18864.
    PubMed    
    Abstract available

  17. SONG Y, Zou J, Choi KS, Lei B, et al
    Cell classification with worse-case boosting for intelligent cervical cancer screening.
    Med Image Anal. 2023;91:103014.
    PubMed    
    Abstract available

  18. MONK BJ, Colombo N, Tewari KS, Dubot C, et al
    First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826.
    J Clin Oncol. 2023 Nov 1:JCO2300914. doi: 10.1200/JCO.23.00914.
    PubMed    
    Abstract available

  19. YOO SS, Katsarakes P, Gashi J, Kim E, et al
    Non-thermal Acoustic Enhancement of Chemotherapeutic Effects of Cisplatin on Xenografted Cervical Cancer in Mice.
    Anticancer Res. 2023;43:4793-4800.
    PubMed    
    Abstract available

  20. LI Y, Shen F, Tan Q, Chen Y, et al
    Research Progress of Immuno-Inhibitory Receptors in Gynecological Cervical Cancer.
    Technol Cancer Res Treat. 2023;22:15330338231208846.
    PubMed    
    Abstract available

  21. CHENG H, Long J, Su J, Chu J, et al
    Mechanism of Paris polyphylla saponin II inducing autophagic to inhibit angiogenesis of cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2023.
    PubMed    
    Abstract available

  22. AYTAC I, Guven Aytac B, Postaci A
    Inadvertent hypothermia in patients undergoing brachytherapy under monitored anesthesia care: A prospective observational cohort study.
    Medicine (Baltimore). 2023;102:e35735.
    PubMed    
    Abstract available

  23. TAN J, Gong R, Zhang Q, Zheng Y, et al
    Meta-analysis of clinical efficacy of electroacupuncture versus conventional treatment for postoperative urinary retention in cervical cancer.
    Medicine (Baltimore). 2023;102:e35580.
    PubMed    
    Abstract available

  24. WU Y, Mou J, Liu Y, Zheng W, et al
    Association of LncRNA PCBP1-AS1 with cancer occurrence and development: A review.
    Medicine (Baltimore). 2023;102:e35631.
    PubMed    
    Abstract available

  25. SIKANDER M, Malik S, Apraku J, Kumari S, et al
    Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer.
    ACS Omega. 2023;8:38839-38848.
    PubMed    
    Abstract available

  26. HASANKHANI MB, Jahani Y, Bazrafshan A, Yazdizadeh A, et al
    Factors Affecting Survival of Patients with Cervical Cancer.
    Iran J Public Health. 2023;52:2216-2224.
    PubMed    
    Abstract available

  27. WU D, Liu P, Song D, Wang H, et al
    Implementing the free HPV vaccination for adolescent girls aged below 14 in Shenzhen, Guangdong Province of China: experience, challenges, and lessons.
    Infect Dis Poverty. 2023;12:98.
    PubMed    
    Abstract available

  28. BERGQVIST L, Heinonen A, Carcopino X, Redman C, et al
    Added value of electrical impedance spectroscopy in adjunction of colposcopy: a prospective cohort study.
    BMJ Open. 2023;13:e074921.
    PubMed    
    Abstract available

  29. ZHANG J, Tian Y
    Construction of prognostic risk markers for cervical cancer combined with anoikis-related genes and their clinical significance.
    Reprod Fertil Dev. 2023 Oct 30. doi: 10.1071/RD23050.
    PubMed    
    Abstract available

  30. WINATA IGS, Yusrika MU, Paramitha PP
    Midwives as the Primary Care Providers: Knowledge, Attitude, Practice, and Skill of Early Detection of Cervical Cancer Using Visual Inspection with Acetic Acid.
    Asian Pac J Cancer Prev. 2023;24:3549-3553.
    PubMed    
    Abstract available

  31. WINATA IGS, Paramitha PP, Yusrika MU
    Correlation between Knowledge, Attitude, and Partner Support Towards Visual Inspection with Acetic Acid Test among Women in Denpasar City, Indonesia.
    Asian Pac J Cancer Prev. 2023;24:3543-3547.
    PubMed    
    Abstract available

  32. BOSE S, Basu P, Mandal R, Chakrabarti J, et al
    A Study of the Impact and Restitutive Efforts of Cervical Cancer Screening during the COVID-19 Pandemic in a Regionsl Cancer Centre in Eastern India.
    Asian Pac J Cancer Prev. 2023;24:3495-3500.
    PubMed    
    Abstract available

  33. GUPTA IJ, Ghosh A, Yadav J, Tuteja JS, et al
    External Beam Radiotherapy Interdigitated with High Dose Rate(HDR) Intracavitary Brachytherapy versus External Beam Radiotherapy followed by Sequential HDR Intracavitary Brachytherapy for Locally Advanced Carcinoma Cervix-Randomized Control Study.
    Asian Pac J Cancer Prev. 2023;24:3441-3445.
    PubMed    
    Abstract available

  34. THIPSANTHIAH K, Kamsa-Ard S, Musika W, Teemuangsai W, et al
    Factors Affecting Non-Histologically Proven Invasive Cancer of the Uterine Cervix that Had an Abnormal Pap Smear: Results of the CCS Program.
    Asian Pac J Cancer Prev. 2023;24:3429-3436.
    PubMed    
    Abstract available

  35. RASI F, Zarredar H, Amini M, Onsori H, et al
    Suppression of E6 Oncogene Induces Apoptosis in CaSki Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2023;24:3389-3395.
    PubMed    
    Abstract available

  36. HAILU G, Wirtu D, Tesfaye T, Getachew M, et al
    Human papillomavirus vaccine uptake and associated factors among adolescent girls in high schools of Nekemte city, Western Ethiopia, 2020.
    BMC Womens Health. 2023;23:560.
    PubMed    
    Abstract available

  37. KOGURE G, Tanaka K, Matsui T, Onuki M, et al
    Intra-Patient Genomic Variations of Human Papillomavirus Type 31 in Cervical Cancer and Precancer.
    Viruses. 2023;15:2104.
    PubMed    
    Abstract available

  38. LIN Y, Lin WY, Lin TW, Tseng YJ, et al
    Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study.
    Viruses. 2023;15:2015.
    PubMed    
    Abstract available

  39. HAN X, Gao Z, Cheng Y, Wu S, et al
    A Therapeutic DNA Vaccine Targeting HPV16 E7 in Combination with Anti-PD-1/PD-L1 Enhanced Tumor Regression and Cytotoxic Immune Responses.
    Int J Mol Sci. 2023;24:15469.
    PubMed    
    Abstract available

  40. SHAKUR A, Lee JYJ, Freeman S
    An Update on the Role of MRI in Treatment Stratification of Patients with Cervical Cancer.
    Cancers (Basel). 2023;15:5105.
    PubMed    
    Abstract available

  41. MAZUREC K, Trzeszcz M, Mazurec M, Streb J, et al
    Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
    Cancers (Basel). 2023;15:5095.
    PubMed    
    Abstract available

  42. MEDICI F, Ferioli M, Forlani L, Laghi V, et al
    Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study).
    Cancers (Basel). 2023;15:5056.
    PubMed    
    Abstract available

  43. BLACKMAN A, Creasman W
    A Case for the Conservative Management of Stage IA Cervical Cancer.
    Cancers (Basel). 2023;15:5051.
    PubMed    
    Abstract available

  44. EASWARAN V, Shorog EM, Alshahrani AA, Mohammad AAS, et al
    Knowledge, Attitudes, and Practices Related to Cervical Cancer Prevention and Screening among Female Pharmacy Students at a Public University in a Southern Region of Saudi Arabia.
    Healthcare (Basel). 2023;11:2798.
    PubMed    
    Abstract available

  45. VOIDAZAN S, Budianu AM, Francisc RF, Kovacs Z, et al
    Assessing the Level of Knowledge and Experience Regarding Cervical Cancer Prevention and Screening among Roma Women in Romania.
    Medicina (Kaunas). 2023;59:1885.
    PubMed    
    Abstract available

  46. ONG WL, Lunca S, Morarasu S, Musina AM, et al
    Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer-A Pilot Study.
    Medicina (Kaunas). 2023;59:1742.
    PubMed    
    Abstract available

  47. ANGHEL B, Serboiu C, Marinescu A, Taciuc IA, et al
    Recent Advances and Adaptive Strategies in Image Guidance for Cervical Cancer Radiotherapy.
    Medicina (Kaunas). 2023;59:1735.
    PubMed    
    Abstract available

  48. FERNANDEZ-AVILA L, Castro-Amaya AM, Molina-Pineda A, Hernandez-Gutierrez R, et al
    The Value of CXCL1, CXCL2, CXCL3, and CXCL8 as Potential Prognosis Markers in Cervical Cancer: Evidence of E6/E7 from HPV16 and 18 in Chemokines Regulation.
    Biomedicines. 2023;11:2655.
    PubMed    
    Abstract available

  49. SCAGLIONE G, Arciuolo D, Travaglino A, Santoro A, et al
    Prognostic Value of Mandard's Tumor Regression Grade (TRG) in Post Chemo-Radiotherapy Cervical Cancer.
    Diagnostics (Basel). 2023;13:3228.
    PubMed    
    Abstract available

  50. YU Z, Zhihui Q, Linrui L, Long L, et al
    Machine Learning-Based Models for Assessing Postoperative Risk Factors in Patients with Cervical Cancer.
    Acad Radiol. 2023 Oct 25:S1076-6332(23)00510-X. doi: 10.1016/j.acra.2023.
    PubMed    
    Abstract available

  51. VOELKER RA
    Cervical Cancer Screening.
    JAMA. 2023 Oct 27. doi: 10.1001/jama.2023.21987.
    PubMed    



  52. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
    Asia Pac J Clin Oncol. 2023 Oct 27. doi: 10.1111/ajco.13997.
    PubMed    


  53. ALONSO-ESPIAS M, Gorostidi M, Gracia M, Garcia-Pineda V, et al
    Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy.
    J Pers Med. 2023;13:1486.
    PubMed    
    Abstract available

  54. MBULAWA ZZA, Mahlangu LL, Makhabane E, Mavivane S, et al
    Poor Cervical Cancer Knowledge and Awareness among Women and Men in the Eastern Cape Province Rural Community.
    Int J Environ Res Public Health. 2023;20:6916.
    PubMed    
    Abstract available

  55. DOVNIK A, Repse Fokter A
    The Role of p16/Ki67 Dual Staining in Cervical Cancer Screening.
    Curr Issues Mol Biol. 2023;45:8476-8491.
    PubMed    
    Abstract available

  56. SABATINO SA, Thompson TD, White MC, Villarroel MA, et al
    Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.
    Prev Chronic Dis. 2023;20:E94.
    PubMed    
    Abstract available

  57. SUPHATTANAPORN O, Saraluck A, Mononai J, Lekskul N, et al
    Prevalence of precancerous gynecological lesions and gynecological cancer in patients undergoing vaginal hysterectomy for pelvic organ prolapse.
    Ann Med. 2023;55:2273428.
    PubMed    
    Abstract available

  58. ZENG H, Dai Q, Jiang D
    A single-institutional retrospective analysis of factors related to vaginal intraepithelial neoplasia.
    BMC Womens Health. 2023;23:548.
    PubMed    
    Abstract available

  59. VELENTZIS LS, Smith MA, Killen J, Brotherton JML, et al
    A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination.
    Elife. 2023;12:e85720.
    PubMed    
    Abstract available

  60. PERKINS RB, Humiston S, Oliver K
    Evidence supporting the initiation of HPV vaccination starting at age 9: Collection overview.
    Hum Vaccin Immunother. 2023;19:2269026.
    PubMed    


  61. LUPIA T, Fornari V, Gaviraghi A, De Rosa FG, et al
    Cerebral cystic echinococcosis reactivation during therapy for squamous tumor of the cervix: possible interactions?
    J Infect Dev Ctries. 2023;17:1348-1350.
    PubMed    


  62. STOEKLE HC, Sekkate S, Ayoubi JM, Bennouna J, et al
    Vaccination against HPV: Easier said than done?
    Hum Vaccin Immunother. 2023;19:2266935.
    PubMed    


  63. HASHIMOTO K, Kumagai T, Nomura K, Miyagawa Y, et al
    Validation of an on-chip p16(ink4a)/Ki-67 dual immunostaining cervical cytology system using microfluidic device technology.
    Sci Rep. 2023;13:17052.
    PubMed    
    Abstract available

  64. HE Y
    A personal tribute to Dr. Harald zur Hausen: A distinguished scientist and caring mentor.
    J Med Virol. 2023;95:e29162.
    PubMed    


  65. UNVER T, Celik-Uzuner S, Erenler AS
    Comparative evaluation of cytotoxic and anti-metastatic function of microbial chondroitin sulfate and animal-originated commercial chondroitin sulfate in cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2023;69:8-14.
    PubMed    
    Abstract available

  66. ZOU Z, Zhang L
    The one-dose schedule opens the door to rapid scale-up of HPV vaccination.
    BMC Med. 2023;21:387.
    PubMed    


  67. BAVOR C, Brotherton JM, Smith MA, Prang KH, et al
    The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study.
    BMC Health Serv Res. 2023;23:1073.
    PubMed    
    Abstract available

  68. GAO X, Xu N, Li Z, Shen L, et al
    Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
    Lancet Oncol. 2023;24:1134-1146.
    PubMed    
    Abstract available

  69. TASSEMBEDO S, Winter CH, Traore IT, Ouattara A, et al
    Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women's knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Bousse hea
    Pan Afr Med J. 2023;45:135.
    PubMed    
    Abstract available

  70. WANG X, Lu X, Chen J, Yi H, et al
    Survival benefit of surgery with postoperative radiotherapy in locally advanced cervical adenocarcinoma: a population-based analysis.
    BMC Surg. 2023;23:299.
    PubMed    
    Abstract available

  71. SHAFIQUE R, Mahjabeen I, Bibi K, Kalsoom F, et al
    miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers.
    Future Oncol. 2023;19:1929-1943.
    PubMed    
    Abstract available

  72. SONG X, Na R, Peng N, Cao W, et al
    Exploring the role of macrophages in the progression from atypical hyperplasia to endometrial carcinoma through single-cell transcriptomics and bulk transcriptomics analysis.
    Front Endocrinol (Lausanne). 2023;14:1198944.
    PubMed    
    Abstract available

  73. AZZI PA, Bastos Russomano F, de Andrade CV, de Camargo MJ, et al
    Frequency of post-treatment disease after excisional procedure in stage IA1 squamous cervical carcinoma - a case series.
    Women Health. 2023;63:747-755.
    PubMed    
    Abstract available

  74. CUI J, Xiao J, Hou Y, Wu X, et al
    Unsupervised Domain Adaptive Dose Prediction via Cross-Attention Transformer and Target-Specific Knowledge Preservation.
    Int J Neural Syst. 2023;33:2350057.
    PubMed    
    Abstract available

  75. LEE VWY, Yip WWL, Tang SYK, Leung MPH, et al
    Efficacy and feasibility of 3D printed redesigned Venezia applicator for treating advanced cervix and recurrent endometrial cancer.
    Phys Med. 2023;114:103150.
    PubMed    
    Abstract available

  76. NIYOTEKA S, Seban RD, Rouhi R, Scarsbrook A, et al
    A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
    Eur J Nucl Med Mol Imaging. 2023;50:4010-4023.
    PubMed    
    Abstract available

  77. JOU J, Kato S, Miyashita H, Thangathurai K, et al
    Cancer-Immunity Marker RNA Expression Levels across Gynecologic Cancers: Implications for Immunotherapy.
    Mol Cancer Ther. 2023;22:1352-1362.
    PubMed    
    Abstract available

  78. KITAZAWA S, Chiyoda T, Nakamura K, Sakai K, et al
    Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
    Int J Clin Oncol. 2023;28:1554-1562.
    PubMed    
    Abstract available

  79. NG JKM, Cheung BHC, Lee DHY, Li JJX, et al
    Detection rates and factors affecting thereof in endometrial hyperplasia, endometrial carcinoma, and cervical glandular lesions on cervical smear.
    Cancer Med. 2023;12:17581-17591.
    PubMed    
    Abstract available

  80. ARROYO MUHR LS, Dillner J
    Biosimilar second-generation human papillomavirus vaccines.
    Lancet Infect Dis. 2023;23:1215-1216.
    PubMed    


  81. WANG T, Su K, Wang L, Shi Y, et al
    Pan-cancer analysis of the oncogenic effects of G-protein-coupled receptor kinase-interacting protein-1 and validation on liver hepatocellular carcinoma.
    Adv Clin Exp Med. 2023;32:1139-1147.
    PubMed    
    Abstract available

  82. HAARSAGER J, Legerton P, DeBats C, Austin G, et al
    Perceptions and implications for cervical screening and self-collection: A qualitative exploration of never and under-screened Queensland women.
    Health Promot J Austr. 2023;34:943-952.
    PubMed    
    Abstract available

  83. PARIDA P, Lewis S, Sharan K, Kamal MV, et al
    Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer.
    Cells. 2023;12:2530.
    PubMed    
    Abstract available

  84. DU N, Li D, Zhao W, Liu Y, et al
    Stratifin (SFN) Regulates Cervical Cancer Cell Proliferation, Apoptosis, and Cytoskeletal Remodeling and Metastasis Progression Through LIMK2/Cofilin Signaling.
    Mol Biotechnol. 2023 Nov 9. doi: 10.1007/s12033-023-00946.
    PubMed    
    Abstract available

  85. YANG H, Ma X, Song B, Wang D, et al
    Golgi Phosphoprotein 3 Promotes Cervical Cancer Progression via Wnt/beta-catenin Mediated Epithelial-Mesenchymal Transition.
    Ann Clin Lab Sci. 2023;53:738-748.
    PubMed    
    Abstract available

  86. MCCLELLAN SP, Unger-Saldana K, Espinosa-Tamez P, Suazo-Zepeda E, et al
    The Cervical Cancer Treatment Gap in Mexico Under Seguro Popular, 2006-2016.
    Health Syst Reform. 2023;9:2272371.
    PubMed    
    Abstract available

  87. ZHANG Y, Chen X, Chen H, Zhang Y, et al
    ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2.
    Crit Rev Immunol. 2023;43:1-13.
    PubMed    
    Abstract available

  88. SANTOS JMO, Tavares V, Gil da Costa RM, Medeiros R, et al
    MiR-150 and miR-155 expression predicts survival of cervical cancer patients: a translational approach to novel prognostic biomarkers.
    Biomarkers. 2023 Nov 9:1-20. doi: 10.1080/1354750X.2023.2269320.
    PubMed    
    Abstract available

  89. WEN J, Huang C, Guo N, Wang W, et al
    Eyelid Metastasis from Cervical Cancer: A Case Report.
    Case Rep Oncol. 2023;16:1311-1317.
    PubMed    
    Abstract available

  90. A D, Li J, Zhang D, Xiao B, et al
    Status of common sexually transmitted infection in population referred for colposcopy and correlation with human papillomavirus infection.
    BMC Womens Health. 2023;23:579.
    PubMed    
    Abstract available

  91. WU RR, Zhou YM, Xie XY, Chen JY, et al
    Delta radiomics analysis for prediction of intermediary- and high-risk factors for patients with locally advanced cervical cancer receiving neoadjuvant therapy.
    Sci Rep. 2023;13:19409.
    PubMed    
    Abstract available

  92. NAZARI AM, Zare-Kaseb A, Arbabi Z, Gholampour MH, et al
    The effect of Benson relaxation technique on cancer patients: a systematic review.
    Support Care Cancer. 2023;31:681.
    PubMed    
    Abstract available

  93. WANG L, Wang C, He Y, Jin M, et al
    Identification of a prognostic model based on immune and hypoxia-related gene expressions in cervical cancer.
    J Obstet Gynaecol. 2023;43:2277242.
    PubMed    
    Abstract available

  94. ZHOU J, Lei N, Tian W, Guo R, et al
    Hypoxic tumor cell-derived small extracellular vesicle miR-152-3p promotes cervical cancer radioresistance through KLF15 protein.
    Radiat Oncol. 2023;18:183.
    PubMed    
    Abstract available

  95. MAEDA M, Mabuchi S, Sakata M, Deguchi S, et al
    Significance of tumor size and number of positive nodes in patients with FIGO 2018 stage IIIC1 cervical cancer.
    Jpn J Clin Oncol. 2023 Nov 1:hyad141. doi: 10.1093.
    PubMed    
    Abstract available

  96. HE J, Xiang L, Zhu T, Wang H, et al
    Maackiain suppresses the development of cervical cancer via AMPK priming autophagy.
    J Pharm Pharmacol. 2023 Nov 2:rgad100. doi: 10.1093.
    PubMed    
    Abstract available

  97. NUJHAT S, Leese HS, Di Lorenzo M, Bowen R, et al
    Advances in screening and diagnostic lab-on-chip tools for gynaecological cancers - a review.
    Artif Cells Nanomed Biotechnol. 2023;51:618-629.
    PubMed    
    Abstract available

  98. TAMAUCHI S, Iyoshi S, Yoshihara M, Yoshida K, et al
    An update of oncologic and obstetric outcomes of radical trachelectomy for early-stage cervical cancer: The need for further minimally invasive treatment.
    J Obstet Gynaecol Res. 2023 Nov 6. doi: 10.1111/jog.15824.
    PubMed    
    Abstract available

  99. LI J
    High-risk HPV-associated ovarian squamous cell carcinoma: A case report and literature review.
    Medicine (Baltimore). 2023;102:e35907.
    PubMed    
    Abstract available

  100. WUTHRICH-GROSSENBACHER U, Midzi N, Mutsaka-Makuvaza MJ, Mutsinze A, et al
    Religious and traditional beliefs and practices as predictors of mental and physical health outcomes and the role of religious affiliation in health outcomes and risk taking.
    BMC Public Health. 2023;23:2170.
    PubMed    
    Abstract available

  101. MOGI K, Koya Y, Yoshihara M, Sugiyama M, et al
    9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins.
    Sci Rep. 2023;13:19208.
    PubMed    
    Abstract available

  102. PATRA S, Ghosal S, Shand H, Mondal R, et al
    Function of gamma delta (gammadelta) T cell in cancer with special emphasis on cervical cancer.
    Hum Immunol. 2023 Nov 4:110724. doi: 10.1016/j.humimm.2023.110724.
    PubMed    
    Abstract available


  103. Correction: Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five subSaharan African countries.
    BMJ Open. 2023;13:e065074corr1.
    PubMed    


  104. WAKWOYA EB, Sadi CG, Sendo EG
    Precancerous cervical lesion screening acceptance among women in Eastern Ethiopia.
    BMJ Open. 2023;13:e073721.
    PubMed    
    Abstract available

  105. M DE CARVALHO T, Man I, Georges D, Saraswati LR, et al
    Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India.
    BMJ Glob Health. 2023;8:e012580.
    PubMed    
    Abstract available

  106. YADAV R, Das PP, Sharma S, Sengupta S, et al
    Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.
    Med Oncol. 2023;40:347.
    PubMed    
    Abstract available

  107. MA Z, Cai Y, Tian C
    ZWINT promotes the proliferation, migration, and invasion of cervical cancer cells by regulating the p53/p21 signaling pathway.
    Chin J Physiol. 2023;66:372-378.
    PubMed    
    Abstract available

  108. DAI J, Zhang S, Shi Y, Xu J, et al
    rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population.
    Pharmgenomics Pers Med. 2023;16:933-948.
    PubMed    
    Abstract available

  109. ZHETPISBAYEVA I, Kassymbekova F, Sarmuldayeva S, Semenova Y, et al
    Cervical Cancer Prevention in Rural Areas.
    Ann Glob Health. 2023;89:75.
    PubMed    
    Abstract available

  110. DANAN ER, Than C, Chawla N, Hoggatt KJ, et al
    Abnormal cervical cancer screening results among US Veteran and non-Veteran participants in the National Health Interview Survey (NHIS).
    Prev Med Rep. 2023;36:102472.
    PubMed    
    Abstract available

  111. LIU KH, Yang W, Tian HP
    Relationships between intravoxel incoherent motion parameters and expressions of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) in patients with cervical cancer.
    Clin Radiol. 2023 Oct 29:S0009-9260(23)00458-0. doi: 10.1016/j.crad.2023.
    PubMed    
    Abstract available

  112. ADEPOJU P
    Nigeria targets almost 8 million girls with HPV vaccine.
    Lancet. 2023;402:1612.
    PubMed    


  113. PAN C, Lin J, Dai X, Jiao L, et al
    An m1A/m6A/m5C-associated long non-coding RNA signature: Prognostic and immunotherapeutic insights into cervical cancer.
    J Gene Med. 2023 Nov 3:e3618. doi: 10.1002/jgm.3618.
    PubMed    
    Abstract available

  114. YEN A, Zhong X, Lin MH, Nwachukwu C, et al
    Optimizing Online Adaptation Timing in the Treatment of Locally Advanced Cervical Cancer.
    Pract Radiat Oncol. 2023 Nov 1:S1879-8500(23)00283.
    PubMed    
    Abstract available

  115. JIN J, Fan Z, Long Y, Li Y, et al
    Matrine induces ferroptosis in cervical cancer through activation of piezo1 channel.
    Phytomedicine. 2023;122:155165.
    PubMed    
    Abstract available

  116. CHRISTENSEN AJ, Mwayi J, Mbabazi J, Juncker M, et al
    Fighting cervical cancer in Africa: a cross-sectional study on prevalence and risk factors for precancerous lesions in rural Uganda.
    Public Health. 2023;225:87-95.
    PubMed    
    Abstract available

  117. ENDALAMAW A, Alganeh H, Azage M, Atnafu A, et al
    Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review.
    Cancer Causes Control. 2023 Nov 4. doi: 10.1007/s10552-023-01813.
    PubMed    
    Abstract available

  118. MENG M, Guo Y, Chen Y, Li X, et al
    Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways.
    Cell Oncol (Dordr). 2023 Nov 4. doi: 10.1007/s13402-023-00891.
    PubMed    
    Abstract available

  119. DENG YR, Chen XJ, Xu CQ, Wu QZ, et al
    A preoperative nomogram predicting risk of lymph node metastasis for early-stage cervical cancer.
    BMC Womens Health. 2023;23:568.
    PubMed    
    Abstract available

  120. PELIZZOLA M, Tanderup K, Chopra S, Jurgenliemk-Schulz IM, et al
    Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis.
    Acta Oncol. 2023;62:1479-1487.
    PubMed    
    Abstract available

  121. TOPKARA S, Sucu S, Cakir AT, Harma M, et al
    Investigation of human papilloma virus frequency in pregnant women.
    J Obstet Gynaecol Res. 2023;49:2728-2733.
    PubMed    
    Abstract available

  122. YOSHINO K, Kurita T, Takahashi F, Nagase S, et al
    Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2020 and Annual Treatment Report for 2015.
    J Obstet Gynaecol Res. 2023;49:2584-2592.
    PubMed    
    Abstract available

  123. ANDRING LM, Corrigan KL, Rooney M, Bailard N, et al
    Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial.
    Pract Radiat Oncol. 2023;13:e538-e546.
    PubMed    
    Abstract available

  124. CHAO A, Wu RC, Lin CY, Chang TC, et al
    Small cell neuroendocrine carcinoma of the cervix: From molecular basis to therapeutic advances.
    Biomed J. 2023;46:100633.
    PubMed    
    Abstract available

  125. CHEN CC, Lai CH, Chang CL, Cheng WF, et al
    Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives.
    J Formos Med Assoc. 2023;122:1213-1218.
    PubMed    
    Abstract available

  126. CONNELLY CF, Collins N, Cimic A, Baskota SU, et al
    Significance of concurrent HPV testing with unsatisfactory Papanicolaou test for prediction of follow-up HPV, Papanicolaou test, and biopsy results.
    Am J Clin Pathol. 2023;160:444-449.
    PubMed    
    Abstract available

  127. VISIOLI CB, Iossa A, Gorini G, Mantellini P, et al
    The 5-year risk of recurrence of grade 2/3 cervical intraepithelial neoplasia after treatment in a population screening programme by human papillomavirus status: A cohort study in central Italy.
    J Med Screen. 2023;30:191-200.
    PubMed    
    Abstract available

  128. YANG S, Yang X, Li C
    Integrated analysis of EREG expression, a gene associated with cervical cancer prognosis.
    Am J Cancer Res. 2023;13:4644-4660.
    PubMed    
    Abstract available

  129. SIVASUBRAMANIAN N, Beeman M, Bharatbhai Patel U, Payalben V, et al
    Knowledge on cervical cancer among Indian women in the state of Gujarat.
    Bioinformation. 2023;19:999-1002.
    PubMed    
    Abstract available

  130. LI Y, Wang W, Tian J, Zhou Y, et al
    Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies.
    Technol Cancer Res Treat. 2023;22:15330338231202650.
    PubMed    
    Abstract available

  131. MAHASE E
    NHS England says it will eliminate cervical cancer by 2040.
    BMJ. 2023;383:p2693.
    PubMed    


  132. AWUA AK
    Ration health resources to save more statistical lives from cervical cancer death in Africa: Why are we allowing them to die?
    Dev World Bioeth. 2023 Nov 15. doi: 10.1111/dewb.12434.
    PubMed    
    Abstract available

  133. TESFAYE D, Weldegebreal F, Ayele F, Dheresa M, et al
    Cervical cancer screening uptake and associated factors among Women Living with Human Immunodeficiency Virus in public hospitals, eastern Ethiopia.
    Front Oncol. 2023;13:1249151.
    PubMed    
    Abstract available

  134. RUTILI DE LIMA C, Khan SG, Shah SH, Ferri L, et al
    Mask region-based CNNs for cervical cancer progression diagnosis on pap smear examinations.
    Heliyon. 2023;9:e21388.
    PubMed    
    Abstract available

  135. DINICU AI, Dioun S, Goldberg M, Crookes DM, et al
    Region of origin and cervical cancer stage in multiethnic Hispanic/Latinx patients living in the United States.
    Cancer Med. 2023 Nov 15. doi: 10.1002/cam4.6697.
    PubMed    
    Abstract available

  136. JAILANI AS, Balqis-Ali NZ, Tang KF, Fun WH, et al
    Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
    BMC Public Health. 2023;23:2243.
    PubMed    
    Abstract available

  137. SABANAYAGAM R, Krishnamoorthy S, Anbuselvam M, Muruganantham B, et al
    A comparative analysis of phyto-components on EGFR binding, viability, and migration in HPV positive ME180 and HPV negative C33A cervical cancer cells.
    Med Oncol. 2023;40:357.
    PubMed    
    Abstract available

  138. LEE NK, Tiro JA, Odunsi K
    Disparities in Gynecologic Cancers.
    Cancer J. 2023;29:343-353.
    PubMed    
    Abstract available

  139. TAN SL, Selvachandran G, Ding W, Paramesran R, et al
    Cervical Cancer Classification From Pap Smear Images Using Deep Convolutional Neural Network Models.
    Interdiscip Sci. 2023 Nov 14. doi: 10.1007/s12539-023-00589.
    PubMed    
    Abstract available

  140. PORTER VL, O'Neill K, MacLennan S, Corbett RD, et al
    Genomic structures and regulation patterns at HPV integration sites in cervical cancer.
    bioRxiv. 2023 Nov 5:2023.11.04.564800. doi: 10.1101/2023.11.04.564800.
    PubMed    
    Abstract available

  141. WANG J, Li M, Zhao L, Zhou B, et al
    Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China.
    Medicine (Baltimore). 2023;102:e35953.
    PubMed    
    Abstract available

  142. JO J, Kim JY, Yun JJ, Lee YJ, et al
    beta-Cyclodextrin Nanophotosensitizers for Redox-Sensitive Delivery of Chlorin e6.
    Molecules. 2023;28:7398.
    PubMed    
    Abstract available

  143. MEREU L, Pecorino B, Ferrara M, Tomaselli V, et al
    Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: Retrospective Single-Center Study.
    Cancers (Basel). 2023;15:5207.
    PubMed    
    Abstract available

  144. KALANTAR R, Curcean S, Winfield JM, Lin G, et al
    Deep Learning Framework with Multi-Head Dilated Encoders for Enhanced Segmentation of Cervical Cancer on Multiparametric Magnetic Resonance Imaging.
    Diagnostics (Basel). 2023;13:3381.
    PubMed    
    Abstract available

  145. YU J, Yuan S, Song J, Yu S, et al
    USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1.
    J Transl Med. 2023;21:807.
    PubMed    
    Abstract available

  146. KABUE M, Gauvreau CL, Daceney N, Bertram MM, et al
    Understanding integrated HPV testing and treatment of pre-cancerous cervical cancer in Burkina Faso, Cote d'Ivoire, Guatemala and Philippines: study protocol.
    Reprod Health. 2023;20:167.
    PubMed    
    Abstract available

  147. FENG T, Cheng B, Sun W, Yang Y, et al
    Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
    BMC Womens Health. 2023;23:599.
    PubMed    
    Abstract available

  148. SOKALE IO, Thrift AP, Montealegre J, Adekanmbi V, et al
    Geographic Variation in Late-Stage Cervical Cancer Diagnosis.
    JAMA Netw Open. 2023;6:e2343152.
    PubMed    
    Abstract available

  149. SEBITLOANE HM, Forestier M, Ginindza TG, Dhlomo W, et al
    Cervical Cancer Screening and Treatment algorithms using Human Papillomavirus testing - lessons learnt from a South African pilot randomized controlled trial.
    Cancer Epidemiol Biomarkers Prev. 2023.
    PubMed    
    Abstract available

  150. ALI AH, Marhoon SE, Taman M
    Emergency Presentation of Invasive Cervical Cancer in Late Pregnancy: A Case Report and Literature Review.
    Cureus. 2023;15:e46900.
    PubMed    
    Abstract available

  151. WANG C, Cheng Y, Song Y, Lei J, et al
    Dosimetric parameters and safety analysis of 3D-printing non-coplanar template-assisted interstitial brachytherapy for non-centrally recurrent cervical cancer.
    Front Oncol. 2023;13:1174470.
    PubMed    
    Abstract available

  152. WANG S, Liu X, Wu Y, Jiang C, et al
    Habitat-based radiomics enhances the ability to predict lymphovascular space invasion in cervical cancer: a multi-center study.
    Front Oncol. 2023;13:1252074.
    PubMed    
    Abstract available

  153. HAOJUE WANG, Xianyi Lu, Ling Fang, Qifeng Shi, et al
    Identification and characterization of differentially expressed genes in cervical cancer: insights from transcriptomic analysis.
    Cell Mol Biol (Noisy-le-grand). 2023;69:276-281.
    PubMed    
    Abstract available

  154. YANG Q, Fu J, Wang M, Fang Y, et al
    MiR-1299 is regulated by KCNQ1OT1 and inhibits cervical cancer progression.
    Cell Mol Biol (Noisy-le-grand). 2023;69:166-173.
    PubMed    
    Abstract available

  155. SCHUURMAN TN, Schaafsma M, To KH, Verhoef VMJ, et al
    Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
    Lancet Oncol. 2023 Nov 9:S1470-2045(23)00467.
    PubMed    
    Abstract available

  156. MAO Z, Wang B, Zhang T, Cui B, et al
    The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications.
    Cell Death Dis. 2023;14:734.
    PubMed    
    Abstract available

  157. PHAN TA, Sarower F, Duan J, Tian JP, et al
    Stochastic dynamics of human papillomavirus delineates cervical cancer progression.
    J Math Biol. 2023;87:85.
    PubMed    
    Abstract available

  158. SIEGLER K, Plaikner A, Hertel H, Hasenbein K, et al
    Oncologic and fertility outcomes after simple trachelectomy in women with early cervical cancer.
    J Minim Invasive Gynecol. 2023 Nov 9:S1553-4650(23)00960.
    PubMed    
    Abstract available

  159. WEN B, Luo L, Zeng Z, Luo X, et al
    MYL9 promotes squamous cervical cancer migration and invasion by enhancing aerobic glycolysis.
    J Int Med Res. 2023;51:3000605231208582.
    PubMed    
    Abstract available

  160. ELBARAZI I, Alam Z, Abdullahi AS, Al Alawi S, et al
    Knowledge, Attitudes and Practices of Women in the UAE Towards Breast and Cervical Cancer Prevention: A Cross-Sectional Study.
    Cancer Control. 2023;30:10732748231211459.
    PubMed    
    Abstract available

  161. ZHANG Y, Zhang W, Du H, Qu X, et al
    A comparative analysis of cycle threshold (Ct) values from Cobas4800 and AmpFire HPV assay for triage of women with positive hrHPV results.
    BMC Infect Dis. 2023;23:783.
    PubMed    
    Abstract available

  162. SCHILLER JT, Kreimer AR
    An HPV vaccine from India: broadening possibilities for cervical cancer control.
    Lancet Oncol. 2023 Nov 7:S1470-2045(23)00535.
    PubMed    


  163. MARCELINA VM, Widyastiti NS, Bramantyo DF, Kristiawan EC, et al
    PREDICTIVE VALUE OF PLATELET COUNT AND PLATELET INDICES IN CERVICAL CANCER PATIENTS WITH EXTERNAL RADIATION THERAPY.
    Wiad Lek. 2023;76:2269-2276.
    PubMed    
    Abstract available

  164. LIN Y, Yang Q
    Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancer.
    Anticancer Drugs. 2023 Nov 13. doi: 10.1097/CAD.0000000000001551.
    PubMed    
    Abstract available

  165. SPENCER JC, Burger EA, Campos NG, Regan MC, et al
    Adapting a model of cervical carcinogenesis to self-identified Black women to evaluate racial disparities in the United States.
    J Natl Cancer Inst Monogr. 2023;2023:188-195.
    PubMed    
    Abstract available

  166. RAN XM, Xiao H, Tang YX, Jin X, et al
    The effect of cuproptosis-relevant genes on the immune infiltration and metabolism of gynecological oncology by multiply analysis and experiments validation.
    Sci Rep. 2023;13:19474.
    PubMed    
    Abstract available

  167. PIMENOFF VN, Gray P, Louvanto K, Eriksson T, et al
    Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts.
    Cell Host Microbe. 2023;31:1921-1929.
    PubMed    
    Abstract available

  168. ANDERSON JR, Yogeshkumar S, Lu E, Yenokyan G, et al
    The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
    BJOG. 2023;130 Suppl 3:158-167.
    PubMed    
    Abstract available

  169. LIN S, Sun Y, Cao C, Zhu Z, et al
    Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma.
    EBioMedicine. 2023;97:104846.
    PubMed    
    Abstract available

  170. COLBERT LE, El Alam MB, Wang R, Karpinets T, et al
    Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring.
    Cancer Cell. 2023;41:1945-1962.
    PubMed    
    Abstract available

  171. VARON M, Salcedo MP, Fellman B, Troisi C, et al
    A Comprehensive Program to Improve Treatment of Precancerous Cervical Lesions in the Rio Grande Valley of Texas.
    J Public Health Manag Pract. 2024;30:89-98.
    PubMed    
    Abstract available

  172. LIN HY, Fu Q, Tseng TS, Zhu X, et al
    Impact of Dietary Quality on Genital Oncogenic HPV Infection in Women.
    J Infect Dis. 2023 May 10:jiad146. doi: 10.1093.
    PubMed    
    Abstract available

  173. JONG FC, Kotzur M, Amiri R, Ling J, et al
    Using a participatory approach to encourage uptake of breast, colorectal, and cervical cancer screening for Scottish Muslim women: a pilot qualitative study.
    Lancet. 2023;402 Suppl 1:S12.
    PubMed    
    Abstract available

  174. WASHINGTON A, Smith L, Anderson G, Randall J, et al
    A Systematic Review of the Effectiveness of Health Education Programs for Cervical Cancer Prevention in Rural Communities: Implications for Promoting Health Equity.
    J Cancer Educ. 2023 Nov 24. doi: 10.1007/s13187-023-02385.
    PubMed    
    Abstract available

  175. CHEN JL, Huang CY, Shih IL, Liou YM, et al
    Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy.
    J Formos Med Assoc. 2023 Nov 22:S0929-6646(23)00440.
    PubMed    
    Abstract available

  176. ZONG Y, Chang Y, Huang K, Liu J, et al
    The role of BATF2 deficiency in immune microenvironment rearrangement in cervical cancer - New biomarker benefiting from combination of radiotherapy and immunotherapy.
    Int Immunopharmacol. 2023;126:111199.
    PubMed    
    Abstract available

  177. LI W, Zhang X, Gao T, Liu L, et al
    Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway.
    J Cancer Res Clin Oncol. 2023 Nov 23. doi: 10.1007/s00432-023-05495.
    PubMed    
    Abstract available

  178. LIU L, Lin J, Deng S, Yu H, et al
    A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapy.
    Cancer Med. 2023 Nov 23. doi: 10.1002/cam4.6745.
    PubMed    
    Abstract available

  179. GUNES AC, Ozgul N, Turkyilmaz M, Kara F, et al
    Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program.
    Cancer Med. 2023 Nov 23. doi: 10.1002/cam4.6740.
    PubMed    
    Abstract available

  180. KNUDSEN AB, Trentham-Dietz A, Kim JJ, Mandelblatt JS, et al
    Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening.
    JAMA Netw Open. 2023;6:e2344698.
    PubMed    
    Abstract available

  181. JIANG L, Xie T, Xia Y, Li F, et al
    ZIP14 Affects the Proliferation, Apoptosis, and Migration of Cervical Cancer Cells by Regulating the P38 MAPK Pathway.
    Curr Cancer Drug Targets. 2023 Nov 21. doi: 10.2174/0115680096250711231024063841
    PubMed    
    Abstract available

  182. CHANG MM, Ma A, Novak EN, Barra M, et al
    A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care.
    Sci Rep. 2023;13:20397.
    PubMed    
    Abstract available

  183. SAVROVA A, Jaal J, Nomm O, Innos K, et al
    Factors associated with advanced-stage diagnosis of cervical cancer in Estonia: a population-based study.
    Public Health. 2023;225:369-375.
    PubMed    
    Abstract available

  184. ALARCON-BARRIOS S, Luvian-Morales J, Castro-Eguiluz D, Delgadillo-Gonzalez M, et al
    Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
    Curr Probl Cancer. 2023;48:101041.
    PubMed    
    Abstract available

  185. HAO S, Meng Q, Sun H, Yang X, et al
    Human papillomavirus type 16 E6 promotes cervical cancer proliferation by upregulating transketolase enzymatic activity through the activation of protein kinase B.
    Mol Carcinog. 2023 Nov 21. doi: 10.1002/mc.23656.
    PubMed    
    Abstract available

  186. XUE J, Yan X, Ding Q, Li N, et al
    Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours.
    Ann Med. 2023;55:2282181.
    PubMed    
    Abstract available

  187. LOFTERS AK, Wu F, Frymire E, Kiran T, et al
    Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    JAMA Netw Open. 2023;6:e2343796.
    PubMed    
    Abstract available

  188. ISLAM S, Shahzad SA, Hassan Bin Asad MH, Mannan A, et al
    Novel amodiaquine analogues to treat cervical cancer and microbial infection in the future.
    Future Med Chem. 2023 Nov 20. doi: 10.4155/fmc-2023-0245.
    PubMed    
    Abstract available

  189. RUSSO L, Pasciuto T, Lupinelli M, Urbano A, et al
    The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.
    Eur Radiol. 2023 Nov 20. doi: 10.1007/s00330-023-10443.
    PubMed    
    Abstract available

  190. BOGANI G, Sopracordevole F, Ciavattini A, Ghelardi A, et al
    HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination.
    Tumori. 2023 Nov 17:3008916231208344. doi: 10.1177/03008916231208344.
    PubMed    
    Abstract available

  191. KRISHNAMOORTHY S, Muruganantham B, Yu JR, Park WY, et al
    Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer.
    Comput Biol Med. 2023;167:107592.
    PubMed    
    Abstract available

  192. NAERT E, Decruyenaere A, Bultijnck R, De Jaeghere EA, et al
    Vaginal morbidity, sexual functioning, and health-related quality of life in cervical cancer survivors: a cross-sectional multicenter study (VAMOS).
    Support Care Cancer. 2023;31:703.
    PubMed    
    Abstract available

  193. CHEN Z, Xu Z, Wang Q, Wang L, et al
    Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis.
    Cell Cycle. 2023 Nov 16:1-18. doi: 10.1080/15384101.2023.2281768.
    PubMed    
    Abstract available

  194. LIU Y, Wang S, Liu J, Su M, et al
    Characteristics of vaginal microbiota in various cervical intraepithelial neoplasia: a cross-sectional study.
    J Transl Med. 2023;21:816.
    PubMed    
    Abstract available

  195. YANG L, Lei Y, Huang Z, Geng M, et al
    An interactive nuclei segmentation framework with Voronoi diagrams and weighted convex difference for cervical cancer pathology images.
    Phys Med Biol. 2023 Nov 16. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  196. HAN K, Zou J, Zhao Z, Baskurt Z, et al
    Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
    J Clin Oncol. 2023 Nov 16:JCO2300954. doi: 10.1200/JCO.23.00954.
    PubMed    
    Abstract available

  197. SILVA TV, Borovac-Pinheiro A, Pacagnella RC
    Estimates of avoided costs attributed to a short cervix screening program to prevent preterm birth from the perspective of the Unified Health System (SUS).
    Rev Saude Publica. 2023;57:87.
    PubMed    
    Abstract available

  198. GRAZIA GA, Bastos DR, Villa LL
    CD40/CD40L expression and its prognostic value in cervical cancer.
    Braz J Med Biol Res. 2023;56:e13047.
    PubMed    
    Abstract available

  199. FOWLER JR, Maani EV, Dunton CJ, Gasalberti DP, et al
    Association of urinary arsenic, polycyclic aromatic hydrocarbons, and metals with cancers among the female population in the US.
    Toxicol Appl Pharmacol. 2023;480:116746.
    PubMed    
    Abstract available

  200. GUO Y, Hua S, Wang B, Wang B, et al
    In situ grown magnetic COF@MOF with a phosphoserine anchor for in-depth N-glycopeptide analysis in serum.
    Analyst. 2023;148:5864-5872.
    PubMed    
    Abstract available

  201. NAGAO A, Okamoto H, Nakayama H, Chiba T, et al
    Assessment of intrafractional motion of the cervix-uterus by MR-guided radiotherapy systemdagger.
    J Radiat Res. 2023;64:967-972.
    PubMed    
    Abstract available

  202. CARDONA-MENDOZA A, Fonseca-Benitez A, Buitrago DM, Coy-Barrera E, et al
    Down-regulation of human papillomavirus E6 oncogene and antiproliferative effect of Schisandra chinensis and Pueraria lobata natural extracts on Hela cell line.
    J Ethnopharmacol. 2024;319.
    PubMed    
    Abstract available

  203. VON BLANCKENBURG P, Kohler C, Petzel A, Julicher A, et al
    Quality of breaking bad news to patients diagnosed with neoplasia of the uterine cervix.
    J Cancer Res Clin Oncol. 2023;149:17215-17222.
    PubMed    
    Abstract available

  204. CHEN L, Chen Y, Shi H, Cai R, et al
    Enhancing prognostic accuracy: a SEER-based analysis for overall and cancer-specific survival prediction in cervical adenocarcinoma patients.
    J Cancer Res Clin Oncol. 2023;149:17027-17037.
    PubMed    
    Abstract available

  205. GROVER S, Lichter KE, Likhacheva A, Jang JW, et al
    The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries.
    Brachytherapy. 2023;22:716-727.
    PubMed    
    Abstract available

  206. GAUTAM H, Mehta S, Nayar N, Kumar N, et al
    Prevalence of human papilloma virus and Chlamydia trachomatis in endometrial and cervical carcinoma: a comparative study in North Indian women.
    Syst Biol Reprod Med. 2023;69:399-409.
    PubMed    
    Abstract available

  207. TANG X, Zhang H, Wang T, Jiang W, et al
    Single and Multiple High-Risk Human Papillomavirus Infections in Histopathologically Confirmed Cervical Squamous Lesions: Incidences, Distribution, and Associated Detection Rates for Precancerous and Cancerous Lesions.
    Lab Invest. 2023;103:100234.
    PubMed    
    Abstract available

  208. SAPRA T, Romm KF, Le D, Berg CJ, et al
    Gaps in Adhering to Pap Testing Recommendations and Related Barriers in a Sample of Young Adults in the US.
    J Cancer Educ. 2023;38:1845-1852.
    PubMed    
    Abstract available

  209. STOLNICU S, Allison D, Praiss AM, Tessier-Cloutier B, et al
    Incidence and Clinicopathologic Characteristics of Human Papillomavirus-independent Invasive Squamous Cell Carcinomas of the Cervix: A Morphologic, Immunohistochemical, and Human Papilloma-Virologic Study of 670 Cases.
    Am J Surg Pathol. 2023;47:1376-1389.
    PubMed    
    Abstract available


  210. HPV testing in older women may improve cervical cancer prevention.
    Cancer. 2023;129:3518.
    PubMed    


  211. FRIEDMAN CF, Ravichandran V, Miller K, Vanderbilt C, et al
    Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
    Clin Cancer Res. 2023 Aug 29:CCR-23-1078. doi: 10.1158/1078-0432.CCR-23-1078.
    PubMed    
    Abstract available

  212. GOEL A, Kapatia G, Parwaiz A, Gupta S, et al
    Commentary on "Comparison of glass and digital slides for cervical cytopathology screening and interpretation".
    Diagn Cytopathol. 2023;51:791-792.
    PubMed    


  213. DE SOUSA VELOZO G, Cordeiro J, Sousa J, Holanda AC, et al
    Comparison of glass and digital slides for cervical cytopathology screening and interpretation.
    Diagn Cytopathol. 2023;51:790.
    PubMed    


  214. DE VELOZO G, Cordeiro J, Sousa J, Holanda AC, et al
    Comparison of glass and digital slides for cervical cytopathology screening and interpretation.
    Diagn Cytopathol. 2023;51:735-743.
    PubMed    
    Abstract available

  215. AISSAOUI O, Phalippou J, Cordoba A, Azais H, et al
    Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:128-134.
    PubMed    
    Abstract available

  216. MCGEE AE, Alibegashvili T, Elfgren K, Frey B, et al
    European consensus statement on expert colposcopy.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:27-37.
    PubMed    
    Abstract available

  217. MONTI E, Salmaso M, Alberico D, Emily Cetera G, et al
    Prevalence of high-grade anal intraepithelial neoplasia in immunocompetent women treated for high-grade cervical intraepithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2023;291:82-87.
    PubMed    
    Abstract available

  218. KUMAR R, Sherwani Z, Lopez M, Vergalasova I, et al
    Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.
    Gynecol Oncol. 2023;179:79-84.
    PubMed    
    Abstract available

  219. WICKENHEISSER NE, Dillon M, Broadwater G, Zacherl K, et al
    Radical hysterectomy case volume and cervical cancer treatment in the era of COVID-19: A multi-site analysis of National Cancer Institute-designated Comprehensive Cancer Centers.
    Gynecol Oncol. 2023;179:70-78.
    PubMed    
    Abstract available

  220. SUMMEY R, Benoit M, Williams-Brown MY
    Survival differences by race and surgical approach in early-stage operable cervical Cancer.
    Gynecol Oncol. 2023;179:63-69.
    PubMed    
    Abstract available

  221. HERMANN CE, Patel JM, Boyd L, Growdon WB, et al
    Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to cervical cancer questions.
    Gynecol Oncol. 2023;179:164-168.
    PubMed    
    Abstract available

  222. GIRDA E, Randall LM, Chino F, Monk BJ, et al
    Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement.
    Gynecol Oncol. 2023;179:115-122.
    PubMed    
    Abstract available

  223. CHAPMAN GC, Smrz SA, Gordon JC, Lynam SK, et al
    Gynecologic cancer care in the first year of the COVID-19 pandemic.
    Gynecol Oncol. 2023;178:138-144.
    PubMed    
    Abstract available

  224. CHEN F, Zhang GN, Lei W, Zhou SG, et al
    Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort study.
    Gynecol Oncol. 2023;178:8-13.
    PubMed    
    Abstract available


  225. Correction to "Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study".
    Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34775.
    PubMed    


  226. BONI SP, Tenet V, Horo A, Heideman DAM, et al
    High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to 2020.
    Int J Cancer. 2023 Nov 9. doi: 10.1002/ijc.34774.
    PubMed    
    Abstract available

  227. TULSIDAS S, Fontes F, Monteiro K, Mussa M, et al
    Cervical cancer in Mozambique: Clinical characteristics, treatment and survival of incident cases admitted to the Oncology Service of Maputo Central Hospital in 2016-2018.
    Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34779.
    PubMed    
    Abstract available

  228. WHITE C, Reynolds S, Murphy K, Keegan H, et al
    Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary screening: Results from the CERVIVA HPV primary screening study in Ireland.
    Int J Cancer. 2023 Aug 26. doi: 10.1002/ijc.34685.
    PubMed    
    Abstract available

  229. EL-ZEIN M, Cheishvili D, Szyf M, Franco EL, et al
    Validation of novel DNA methylation markers in cervical precancer and cancer.
    Int J Cancer. 2024;154:104-113.
    PubMed    
    Abstract available

  230. DHOKOTERA TG, Muchengeti M, Davidovic M, Rohner E, et al
    Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study.
    Int J Cancer. 2023 Sep 8. doi: 10.1002/ijc.34712.
    PubMed    
    Abstract available

  231. FERNANDEZ VILLALOBOS NV, Ruffieux Y, Haas AD, Chinogurei C, et al
    Cervical precancer and cancer incidence among insured women with and without HIV in South Africa.
    Int J Cancer. 2023 Sep 2. doi: 10.1002/ijc.34707.
    PubMed    
    Abstract available

  232. ZHANG Y, Wang C, Zhao Z, Cheng L, et al
    Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: A systematic review with meta-analysis.
    Int J Gynaecol Obstet. 2023 Nov 11. doi: 10.1002/ijgo.15218.
    PubMed    
    Abstract available

  233. SALCEDO MP, Lathrop E, Osman N, Neves A, et al
    The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
    Int J Gynecol Cancer. 2023 Oct 31:ijgc-2023-004958.
    PubMed    
    Abstract available

  234. KOUHEN F, El Ghanmi A
    Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
    Int J Gynecol Cancer. 2023;33:1835.
    PubMed    


  235. NITECKI R, Ramirez PT, Dundr P, Nemejcova K, et al
    MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
    Int J Gynecol Cancer. 2023;33:1684-1689.
    PubMed    
    Abstract available

  236. ALLANSON ER, Burling M, Simcock B, Nicklin J, et al
    The Australian Society of Gynaecological Oncology Western Pacific Liaison group.
    Int J Gynecol Cancer. 2023;33:1819-1820.
    PubMed    


  237. CARUSO G, Bruni S, Lapresa M, De Vitis LA, et al
    Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004928.
    PubMed    
    Abstract available

  238. PARIDA P, Baburaj G, Rao M, Lewis S, et al
    Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004873.
    PubMed    
    Abstract available

  239. HAN K, Colson-Fearon D, Liu ZA, Viswanathan A, et al
    Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the U.S.: A Surveillance, Epidemiology, and End-Results Study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08132.
    PubMed    
    Abstract available

  240. MANTZ C
    Comments on "Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy".
    Int J Radiat Oncol Biol Phys. 2023;117:1143-1144.
    PubMed    


  241. FIELDS EC, Erickson B, Chino J, Small C, et al
    Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2023;117:1138-1142.
    PubMed    


  242. AKINFENWA CA, Allanson E, Ewongwo A, Lumley C, et al
    Mapping of radiation oncology and gynecologic oncology services available to treat the growing burden of cervical cancer in Africa.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08043.
    PubMed    
    Abstract available

  243. CORBEAU A, Heemsbergen WD, Kuipers SC, Godart J, et al
    Predictive factors for toxicity after primary chemoradiation for locally advanced cervical cancer: a systematic review.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08133.
    PubMed    
    Abstract available

  244. LIU Z, Zhang H, Hu X
    Analysis of the expression and mechanism of follistatin?like protein 1 in cervical cancer.
    Oncol Rep. 2023;50:215.
    PubMed    
    Abstract available

  245. REIJTENBAGH D, Godart J, Penninkhof J, Quint S, et al
    Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques.
    Radiother Oncol. 2023;190:110009.
    PubMed    
    Abstract available

  246. LI X, Wei X, Liu X, Wang N, et al
    The analysis of HPV integration sites based on nanopore sequencing and the profiling changes along the course of photodynamic therapy.
    BMC Cancer. 2023;23:1052.
    PubMed    
    Abstract available

  247. BUKOWSKI A, Hoyo C, Vielot NA, Graff M, et al
    Epigenome-wide methylation and progression to high-grade cervical intraepithelial neoplasia (CIN2+): a prospective cohort study in the United States.
    BMC Cancer. 2023;23:1072.
    PubMed    
    Abstract available

  248. MWALIKO E, Itsura P, Keter A, De Bacquer D, et al
    Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.
    BMC Cancer. 2023;23:1104.
    PubMed    
    Abstract available

  249. CHENG Z, Wang H, Yang Z, Li J, et al
    LMP2 and TAP2 impair tumor growth and metastasis by inhibiting Wnt/beta-catenin signaling pathway and EMT in cervical cancer.
    BMC Cancer. 2023;23:1128.
    PubMed    
    Abstract available

  250. ZHANG H, Yang Y, Xing W, Li Y, et al
    Expression and gene regulatory network of S100A16 protein in cervical cancer cells based on data mining.
    BMC Cancer. 2023;23:1124.
    PubMed    
    Abstract available

  251. GLINSKA P, Komerska K, Janik B, Olkowicz J, et al
    HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
    BMC Cancer. 2023;23:1118.
    PubMed    
    Abstract available

  252. WANG J, Elfstrom KM, Lagheden C, Eklund C, et al
    Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
    PLoS Med. 2023;20:e1004304.
    PubMed    
    Abstract available

  253. QAQISH A, Abdo N, Abbas MM, Saadeh N, et al
    Awareness and knowledge of physicians and residents on the non-sexual routes of human papilloma virus (HPV) infection and their perspectives on anti-HPV vaccination in Jordan.
    PLoS One. 2023;18:e0291643.
    PubMed    
    Abstract available

  254. ZHAO X, Gopalappa C
    Joint modeling HIV and HPV using a new hybrid agent-based network and compartmental simulation technique.
    PLoS One. 2023;18:e0288141.
    PubMed    
    Abstract available

  255. DESTA M, Getaneh T, Yeserah B, Worku Y, et al
    Correction: Cervical cancer screening utilization and predictors among eligible women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0294799.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;